Seres Therapeutics, Inc. Balance Sheet
MCRB|10 years of annual SEC 10-K data (FY2015-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$138M
FY2025
Cash
$46M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$14M
FY2025
Seres Therapeutics, Inc. had $138M in total assets and $14M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45.8M | $163.0M | $163.0M | $180.0M | $116.0M | $65.1M | $85.8M | $73.9M | $114.2M | $1.7M |
| Accounts Receivable | $157.0K | - | - | - | $9.4M | $1.8M | - | - | - | - |
| Inventory | - | $0 | - | - | - | - | - | - | - | - |
| Current Assets | $49.4M | $194.8M | $194.8M | $303.6M | $268.8M | $100.2M | $92.7M | $155.1M | $198.4M | $207.6M |
| PP&E (Net) | $7.6M | $23.0M | $23.0M | $17.9M | $13.9M | $19.5M | $26.3M | $32.9M | $36.1M | $7.8M |
| Total Assets | $138.2M | $348.8M | $348.8M | $354.9M | $342.9M | $132.4M | $120.5M | $189.5M | $272.6M | $216.9M |
| Current Liabilities | $19.3M | $85.6M | $85.6M | $82.3M | $46.4M | $46.0M | $42.0M | $31.6M | $30.5M | $10.9M |
| Total Debt | - | $110.0M | - | - | - | - | - | - | - | - |
| Shareholders' Equity | $13.8M | $131.5M | $174.8M | -$48.3M | -$48.0M | $60.7M | $132.6M | $205.4M | -$26.7M | -$11.1M |